(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) announced Tuesday that its collaboration partner, Kissei Pharmaceutical Co., Ltd., has released positive topline results from its Phase 3 clinical trial ...
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage drug development company Rigel Pharmaceuticals has ...
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) announced, overall, the company expects to report net product sales of $104.3 million in 2023, representing 36% growth over 2022. For the fourth quarter, ...
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) and The University of Texas MD Anderson Cancer Center announced a multi-year strategic development collaboration to expand the evaluation of REZLIDHIA in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback